Litigation for NIVOLUMAB
✉ Email this page to a colleague
US Court Litigation for NIVOLUMAB
Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
---|---|---|---|---|---|---|---|---|
10,143,723 | ⤷ Subscribe | ⤷ Subscribe | 2022-03-17 | 2023-08-30 | 35:271 Patent Infringement | District Court, D. Delaware | Plaintiff | ⤷ Subscribe |
10,143,723 | ⤷ Subscribe | ⤷ Subscribe | 2021-12-31 | 99:9999 (Miscellaneous Case - Cause Not Known) | District Court, D. Delaware | None | ⤷ Subscribe | |
10,172,808 | ⤷ Subscribe | ⤷ Subscribe | 2022-03-17 | 2023-08-30 | 35:271 Patent Infringement | District Court, D. Delaware | Plaintiff | ⤷ Subscribe |
10,172,808 | ⤷ Subscribe | ⤷ Subscribe | 2021-12-31 | 99:9999 (Miscellaneous Case - Cause Not Known) | District Court, D. Delaware | None | ⤷ Subscribe | |
>Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
Patent Trial and Appeal Board Cases for NIVOLUMAB
Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
---|---|---|---|---|---|---|---|---|---|---|
10,034,938 | Replimune Limited et al. | ⤷ Subscribe | 2022-11-02 | 11-02-2022 | Inter partes review | ⤷ Subscribe | 05-18-2023 | ⤷ Subscribe | ||
9,855,302 | Genome & Company | ⤷ Subscribe | 2018-10-02 | 10-02-2018 | Post-grant review | ⤷ Subscribe | 04-15-2019 | ⤷ Subscribe | ||
>Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |